粤81品牌入选《中国500最具价值品牌》，知名药企登榜

Core Insights - The "World Brand Conference" held on June 18 revealed the "Top 500 Most Valuable Chinese Brands" list, with Guangdong brands showing strong performance, including Kangchen Pharmaceutical, which ranked 454th with a brand value of 14.755 billion yuan, a 30% increase from 11.236 billion yuan in 2023, moving up 8 places [1][4][6]. Group 1: Brand Value and Rankings - The "Top 500 Most Valuable Chinese Brands" list is a significant indicator of brand competition, utilizing the "income present value method" for brand valuation, which incorporates consumer research, competitive analysis, and future income predictions [4]. - The entry threshold for the list has increased to 4.291 billion yuan by 2025, with notable companies like State Grid, China Petroleum, Haier, Tencent, Moutai, and others making the list [4]. Group 2: Regional Brand Strength - Guangdong continues to demonstrate strong brand strength with 81 brands on the list, maintaining its position as the second-highest region, showcasing its industrial cluster advantages and brand competitiveness across sectors like pharmaceuticals, manufacturing, and technology [6]. - Kangchen Pharmaceutical, as a representative in the healthcare sector, has achieved significant brand value growth through strategic focus and continuous innovation [6]. Group 3: Company Overview and Innovations - Established in 1997, Kangchen Pharmaceutical focuses on modern traditional Chinese medicine and medical imaging agents, adhering to the mission of "inheriting the past and innovating for the future" [8]. - The company has developed six major products with over 100 million yuan in sales, covering over 30 countries and regions, and has been recognized for its flagship product, Uremic Clear Granules, as a "Guangdong Provincial Famous Brand" [8]. - Kangchen is embracing technological transformation by collaborating with leading global AI companies to enhance drug research and development efficiency, aiming to become a leader in the AI-driven pharmaceutical development era [8].